Neurocrine Bioscienc (NQ: NBIX )
132.00
-0.54
(-0.41%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 19, 2024
Add to My Watchlist
Price and VolumeDetailed Quote
Top NewsMore NewsPerformanceMore NewsRead More
Where Neurocrine Biosciences Stands With Analysts
April 10, 2024
Why Quality-Oriented Investors Should Consider NASDAQ:NBIX.
March 15, 2024
Decoding 8 Analyst Evaluations For Neurocrine Biosciences
March 13, 2024
Amicus Therapeutics Stock Sees RS Rating Improve To 74
March 05, 2024
Beam Therapeutics Stock Jumps To Higher RS Level On Earnings Beat
February 27, 2024
Agios Pharmaceuticals Stock Earns RS Rating Upgrade; Hits Key Benchmark
February 23, 2024
Beam Therapeutics Stock Shows Healthy Relative Strength Improvement
February 16, 2024
Alkermes Stock Gets RS Rating Upgrade; Profits Surge
February 15, 2024
CRISPR Therapeutics Stock Shows Rising Relative Strength, Hits 90+
February 13, 2024
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions. |
|